Why choose us

We create significant customer value by drawing on over 35 years in business, leveraging accumulated capabilities, experience, and market position.

Your end-to-end partner

SHL Medical provides end-to-end solutions that cover the full drug delivery value chain, offering peace of mind from design and development to testing, final assembly, labeling, and packaging. Our integrated approach ensures success across the entire product lifecycle by embedding quality, regulatory, and supply chain expertise into every project. This comprehensive strategy meets clinical, commercial, and aftermarket needs, delivering optimal development timelines and cost structures.

By staying ahead of the ever-changing market landscape, SHL continues to provide sustainable benefits and innovative solutions across the value chain, ensuring efficiency and reliability for our partners.

Download company leaflet Our services

What sets SHL Medical apart?

Why global pharma companies partner with us

Our entrepreneurial spirit and visionary foundation have driven our success since our inception in 1989. Through groundbreaking innovations, we have reshaped the drug delivery industry. By collaborating closely with our partners, we turn ambitious projects into successful solutions.

Our track record

We have the longest experience and strongest track record in the autoinjector market.

Read about our track record here.

Celebrating Molly® Brief history of Molly® autoinjectors-high

We innovate for you

We are dedicated to advancing drug delivery systems that expand the possibilities for self-injection, ensuring broader treatment options.

Read about innovation here.

Elexy Multiple 1PU+2 Cassettes - Molly and Maggie

Closer to customers

Largest manufacturing output on three continents. By early 2027, SHL Medical will be the only autoinjector company with manufacturing operations across North America, Europe, and Asia.
See our locations here.

Seamless scalability

The scalability from low-to-high-volume supply with options of asset ownership allows for flexible, high-quality solutions.

Read about scale up here.

Why SHL is the best partner for biotech startups

The learnings from helping customers and patients all over the world have enriched us with unparalleled experience. Regardless of our customers’ changing needs, our agile and holistic support will always be there to provide the most reliable customer journey, from ideation to products with longevity.

We grow with you

We are ready to invest in your growth. Our scalable platforms allow us to work on projects from small batches to tens of millions of devices.

End-to-end solution

We support you throughout all phases of device development, ensuring you get the right solution and expert insights at every stage.

SHL-Medical-Office People Zug Konstantin KK5D8369

Our demonstrated expertise

We have the longest expertise which allows us to tackle very different types of projects.

Low investment and risk

You can fully outsource device manufacturing, leveraging our in-house manufacturing assets without having to invest in your own.

Driving customer success

A Molly-powered European first

Developed with Samsung Bioepis and Sandoz, the Molly platform supported the launch of Europe's first ustekinumab biosimilar autoinjector.

Enabling precision eye care

Developed with Bayer, SHL Medical's Micro Dosing Device enables precise dosing for intravitreal injections in premature infants.